Regulation by resveratrol of the cellular factors mediating liver damage and regeneration after acute toxic liver injury

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 3, 2014, Pages 603-613

  Chan, Che Chang ^a,b   Lee, Kuei Chuan ^a,b   Huang, Yi Hsiang ^a,b   Chou, Chung Kai ^a   Lin, Han Chieh ^a   Lee, Fa Yauh ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; CXCL10; Cytokine; Hepatocyte; Regeneration; Resveratrol

Indexed keywords

4 HYDROXYNONENAL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CASPASE 3; CASPASE 8; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL XL; RESVERATROL; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; KUPFFER CELL; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER REGENERATION; LIVER TOXICITY; MALE; MOUSE; NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STELLATE CELL;

APOPTOSIS; CXCL10; CYTOKINE; HEPATOCYTE; REGENERATION; RESVERATROL;

ALANINE TRANSAMINASE; ALDEHYDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; CASPASE 3; CASPASE 8; CHEMOKINE CXCL10; CYTOKINES; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; INFLAMMATION MEDIATORS; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; NECROSIS; PHYTOTHERAPY; SESQUITERPENES; STILBENES;

EID: 84897588939     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12366     Document Type: Article

References (39)

1. Rutherford A, Chung RT. Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin. Liver Dis. 2008; 28: 167-174.
2. Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int. J. Hepatol. 2012; 2012: 853175.
3. Zhang W, Wang M, Xie HY etal. Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation. Transplant. Proc. 2007; 39: 1332-1337.
4. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front. Physiol. 2012; 3: 56.
5. Tilg H. Cytokines and liver diseases. Can. J. Gastroenterol. 2001; 15: 661-668.
6. Diehl AM. Cytokine regulation of liver injury and repair. Immunol. Rev. 2000; 174: 160-171.
7. Possamai LA, Antoniades CG, Anstee QM etal. Role of monocytes and macrophages in experimental and human acute liver failure. World J. Gastroenterol. 2010; 16: 1811-1819.
8. Aoki K, Ohmori M, Takimoto M, Ota H, Yoshida T. Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur. J. Pharmacol. 1997; 336: 43-49.
9. Alric L, Orfila C, Carrere N etal. Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4. Inflamm. Res. 2000; 49: 700-707.
10. Pallottini V, Martini C, Bassi AM, Romano P, Nanni G, Trentalance A. Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J. Hepatol. 2006; 44: 368-374.
11. Llacuna L, Mari M, Lluis JM, Garcia-Ruiz C, Fernandez-Checa JC, Morales A. Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am. J. Pathol. 2009; 174: 1776-1785.
12. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006; 26: 1175-1186.
13. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004; 5: 836-847.
14. Jia C. Advances in the regulation of liver regeneration. Expert Rev. Gastroenterol. Hepatol. 2011; 5: 105-121.
15. Fujiyoshi M, Ozaki M. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci. 2011; 18: 13-22.
16. Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid. Redox Signal. 2001; 3: 1041-1064.
17. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health-a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 2011; 55: 1129-1141.
18. Smoliga JM, Vang O, Baur JA. Challenges of translating basic research into therapeutics: resveratrol as an example. J. Gerontol. A. Biol Sci. Med Sci 2012; 67: 158-167.
19. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006; 5: 493-506.
20. Chan CC, Cheng LY, Lin CL, Huang YH, Lin HC, Lee FY. The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury. Mol. Nutr. Food Res. 2011; 55: 1841-1849.
21. Fan G, Tang JJ, Bhadauria M etal. Resveratrol ameliorates carbon tetrachloride-induced acute liver injury in mice. Environ. Toxicol. Pharmacol. 2009; 28: 350-356.
22. Chan CC, Cheng LY, Lu J etal. The role of interferon-gamma inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation. PLoS ONE 2012; 7: e50577.
23. Riahi Y, Cohen G, Shamni O, Sasson S. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 2010; 299: E879-886.
24. Lee SJ, Seo KW, Yun MR etal. 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways. Free Radic. Biol. Med. 2008; 45: 1487-1492.
25. Traeger T, Mikulcak M, Eipel C etal. Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis. Eur. J. Gastroenterol. Hepatol. 2010; 22: 1039-1049.
26. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006; 354: 610-621.
27. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 2006; 6: 907-918.
28. Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 2009; 49: 676-688.
29. Narumi S, Tominaga Y, Tamaru M etal. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 1997; 158: 5536-5544.
30. Zeremski M, Petrovic LM, Chiriboga L etal. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008; 48: 1440-1450.
31. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J. Immunol. 2001; 167: 399-406.
32. Damianaki A, Bakogeorgou E, Kampa M etal. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell. Biochem. 2000; 78: 429-441.
33. Kampa M, Hatzoglou A, Notas G etal. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr. Cancer 2000; 37: 223-233.
34. Kirimlioglu H, Ecevit A, Yilmaz S, Kirimlioglu V, Karabulut AB. Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy. Transplant. Proc. 2008; 40: 285-289.
35. Wang G, Guo X, Chen H etal. A resveratrol analog, phoyunbene B, induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Bioorg. Med. Chem. Lett. 2012; 22: 2114-2118.
36. Parekh P, Motiwale L, Naik N, Rao KV. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp. Toxicol. Pathol. 2011; 63: 167-173.
37. Zhai Y, Shen XD, Gao F etal. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 2008; 47: 207-214.
38. Njoku DB, Li Z, Mellerson JL etal. IP-10 protects while MIP-2 promotes experimental anesthetic hapten-induced hepatitis. J. Autoimmun. 2009; 32: 52-59.
39. Bone-Larson CL, Hogaboam CM, Evanhoff H, Strieter RM, Kunkel SL. IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J. Immunol. 2001; 167: 7077-7083.